
ERT and Bioclinica Merge
READ MORE
ERT ANNOUNCES
COGSTATE
PARTNERSHIP
READ MORE
ERT ANNOUNCES
COGSTATE
PARTNERSHIP


REINVENTING ENDPOINT
MEASUREMENT IN
CLINICAL TRIALS
LEARN MORE




VIRTUAL VISITS
LEARN MOREVIRTUAL VISITS

A BETTER WAY TO
MANAGE YOUR
CLINICAL DEVELOPMENT
LEARN MORE
A BETTER WAY TO
MANAGE YOUR
CLINICAL DEVELOPMENT
5.2M+
Patients Enrolled
230K
Sites Supported
600+
Drug Approvals
15K
Trials Managed
Deliver Your Vaccine Trials. Faster.
ERT speeds up your vaccine clinical studies, capturing patient data quickly and accurately with its dedicated vaccines ePRO solution.
NEWS & EVENTS
LATEST NEWS
December 10, 2020
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology
ERT and Bioclinica to Merge, Creating a Global Leader in Clinical Trial Endpoint Technology PHILADELPHIA ...
December 22, 2020
ERT’s Year in Review: 11 Pieces You Don’t Want to Miss
2020 was a year of evolution in the clinical research industry. In the face of unexpected and unprecedented challenges, we were inspired to adapt.
September 29, 2020
FDA Guidance Overview: Assessing Symptoms in Clinical Trials Aimed to Prevent and Treat COVID-19
Learn the FDA’s position on assessing symptoms in clinical trials of drugs and biologics for the prevention and treatment of COVID-19.